JNJ

J&J, Eli Lilly join $85M financing for newly unveiled gene editing biotech Stylus
Fierce Biotech
Tue, 05/13/25 - 11:10 am
Stylus Medicine
funding
JNJ
Eli Lilly
gene editing
Johnson & Johnson (JNJ) reports Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis
Marketscreener
Fri, 05/9/25 - 08:59 am
JNJ
clinical trials
icotrokinra
psoriasis
In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen
Fierce Pharma
Thu, 05/8/25 - 10:56 pm
FDA
Richard Pazdur
Marty Makary
cancer
oncology
JNJ
Pfizer
Roche
Urogen
J&J survey finds pace of oncology innovation is overwhelming physicians
Fierce Pharma
Thu, 05/8/25 - 11:17 am
JNJ
oncology
oncologists
physicians
innovation
Amgen’s Stelara biosimilar gets off to fast start
BioPharma Dive
Sun, 05/4/25 - 12:00 pm
Amgen
Stelara
biosimilars
JNJ
J&J secures FDA OK for immune drug touted as future blockbuster
BioPharma Dive
Wed, 04/30/25 - 11:39 pm
JNJ
FDA
Imaavy
nipocalimab
myasthenia gravis
As J&J aims to 'fundamentally change' how bladder cancer type is treated, ImmunityBio plays defense
Fierce Pharma
Tue, 04/29/25 - 08:16 am
JNJ
TAR-200
bladder cancer
ImmunityBio
Trump’s tariff effect has dominated medtech earnings calls
Medtech Dive
Tue, 04/29/25 - 08:15 am
Medtech
earnings
JNJ
Abbott Labs
Boston Scientific
tariffs
Data readout puts J&J's bladder cancer drug back on track
Pharmaphorum
Tue, 04/22/25 - 11:00 am
JNJ
bladder cancer
TAR-200
clinical trials
J&J’s electrophysiology sales dip amid slow Varipulse start
Medtech Dive
Thu, 04/17/25 - 11:32 am
JNJ
Medtech
PFA
Medtronic
Boston Scientific
earnings
Varipulse
J&J CEO Duato Urges Tax Fix, Not Tariffs To Drive US Pharma Manufacturing
BioSpace
Tue, 04/15/25 - 07:55 pm
JNJ
Joaquin Duato
drug manufacturing
taxes
tariffs
Pharma CEOs
Johnson & Johnson Q1 2025 slides reveal strong growth across diversified portfolio
Investing.com
Tue, 04/15/25 - 11:25 am
JNJ
earnings
J&J reports analysis from Phase III trial of plaque psoriasis treatment
Clinical Trials Arena
Fri, 04/11/25 - 11:20 am
JNJ
clinical trials
plaque psoriasis
icotrokinra
Five Biggest Drug Face-Offs in Pharma History
BioSpace
Wed, 04/9/25 - 11:38 am
competition
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Pfizer
Bayer
JNJ
Eliquis
Xarelto
Biogen
Eisai
Eli Lilly
Leqembi
Kisunla
AbbVie
Humira
Stelara
AstraZeneca
Calquence
Imbruvica
Boosted by March Madness, Tremfya takes the lead in TV pharma ad rankings
Medical Marketing and Media
Mon, 04/7/25 - 11:13 am
DTC advertising
television ads
JNJ
AbbVie
Tremfya
Skyrizi
J&J’s psoriatic arthritis therapy trial meets endpoints
Clinical Trials Arena
Mon, 04/7/25 - 11:05 am
JNJ
clinical trials
psoriatic arthritis
Tremfya
The top 10 pharma R&D budgets for 2024
Fierce Biotech
Fri, 04/4/25 - 11:30 am
R&D
Merck
JNJ
Roche
AstraZeneca
AbbVie
Bristol Myers Squibb
Eli Lilly
Pfizer
Novartis
Sanofi
M&A recap: Big pharma starts the year mostly avoiding billion-dollar deals
BioPharma Dive
Fri, 04/4/25 - 11:26 am
M&A
Big Pharma
JNJ
Intra-Cellular Therapies
IDRx
GSK
Novartis
Anthos Therapeutics
J&J Plan for Bankruptcy to End Talc Cancer Claims Rejected
MSN/Reuters
Mon, 03/31/25 - 11:04 pm
JNJ
legal
bankruptcy
J&J combo signals new era in EGFR lung cancer with survival win against AstraZeneca's Tagrisso
Fierce Pharma
Wed, 03/26/25 - 10:25 pm
JNJ
EGFR lung cancer
Rybrevant
Lazcluze

Pages